IBD & Intestinal Disorders
From the AGA Journals
Crohn’s disease indicators manifest years before diagnosis
Complicated CD at diagnosis is associated with a distinct serologic profile years before diagnosis.
Member Spotlight
Bridging the gap between GI disorders and nutrition
Renee Euler, MS, RD, LD has made it her life’s work to navigate GI disorders with physicians and patients alike.
Latest News
CDC alerts clinicians to signs of alpha-gal syndrome
The AGA issued a Clinical Practice Update on alpha-gal syndrome in February.
From the AGA Journals
Crohn’s link seen for ultraprocessed foods
A meta-analysis of longitudinal cohort studies showed that people who consumed more ultraprocessed foods saw higher incidence of Crohn’s.
From the Journals
Study documents obesity-related defecation disorders
“These results support the notion that rectal evacuation disorder/incomplete evacuation may be an important underlying mechanism for fecal...
Conference Coverage
Noteworthy advances in treatment and management of IBD
A team of leading GI clinicians describes the most noteworthy achievements in IBD research over the last year.
Latest News
Defining difficult-to-treat inflammatory bowel disease
A group of experts held a consensus meeting to propose a common operative definition for “difficult-to-treat IBD.”
From the AGA Journals
Nearly 1 in 100 people diagnosed with IBD in the U.S.
The prevalence of IBD in the United States has been gradually increasing over the last decade.
Feature
Humira biosimilars: Five things to know
The launch of eight adalimumab biosimilars so far in 2023 ended Humira’s 20-year monopoly, but it’s not clear yet if these discounted drugs will...
Conference Coverage
Celiac disease: Update on diagnosis and monitoring
The best initial serology test for diagnosis in suspected celiac disease is the tissue transglutaminase IgA antibody.